Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 3, 2009, Pages 179-185

  Sakai, Yukinao ^a   Sakai, Saori ^a   Otsuka, Tomoyuki ^a   Ohno, Dai ^a   Murasawa, Tsuneo ^a   Munakata, Kazuo ^a   Mizuno, Kyoichi ^b  

^a NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

DAS28; Infliximab; Leukocytapheresis; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; METHOTREXATE; NAFAMSTAT MESILATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ABSENCE OF SIDE EFFECTS; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CYTAPHERESIS; DEVICE; DISEASE ACTIVITY; DRUG EFFICACY; EQUIPMENT; ERYTHROCYTE SEDIMENTATION RATE; EVALUATION; FEMALE; HUMAN; LEUKAPHERESIS; LEUKOCYTAPHERESIS; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 66549128404     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00657.x     Document Type: Conference Paper

References (19)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002 46 : 328 46.
2. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis with the first 2 years of disease. J Rheumatol 1998 16 : 585 91.
3. Keystone EC, Kavanaugh A. What to do with TNF failures? Expert Opin Drug Saf 2005 4 : 149 55.
4. Ueki Y, Yamasaki S, Kanemoto Y et al. Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology 2000 39 : 165 71.
5. Hidaka T, Suzuki K. Efficacy of filtration leukocytapheresis on rheumatoid arthritis and vasculitis. Ther Apher 1997 1 : 212 14.
6. Kempe K, Tsuda H, Yang K, Yamaji K, Kanai Y, Hashimoto H. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate. Ther Apher Dial 2004 8 : 197 205. (Pubitemid 38900424)
7. Eguchi K, Saito K, Kondo M, Hidaka T, Ueki Y, Tanaka Y. Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis. Mod Rheumatol 2007 17 : 481 5.
8. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 24.
9. Prevoo ML, van't Hof MA, Kuper HH et al. Modified disease activity score that include the twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995 38 : 44 8.
10. Miyasaka N, Takeuchi T, Eguchi K, Japanese O. Guidelines for the use of infliximab and methotrexate. Mod Rheumatol 2005 15 : 4 8.
11. The department of rheumatology, University Medical Centre Nijmegen. DAS-Score.nl Cited 11 February 2009. Available from URL: http://www.das-score. nl/
12. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor (TNF) α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998 41 : 1552 63.
13. Wolbink GJ, Vis M, Lems W et al. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheum 2006 54 : 711 15.
14. Azuma T, Ishimaru H, Hatta K, Kori Y. Improved response to infliximab after leukocytapheresis in a patient with rheumatoid arthritis. Mod Rheumatol 2007 17 : 253 5.
15. Hata A, Nakajima M, Shoda T et al. A case of rheumatoid arthritis with improved response to infliximab following leukocytapheresis. Nippon Apheresis Gakkai Zassi 2007 26 : 350 3.
16. Onuma S, Yamaji K, Kempe K et al. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis. Ther Apher Dial 2006 10 : 404 11.
17. Yamaji K, Onuma S, Yasuda M et al. Fluctuations in peripheral blood leukocyte and platelet counts and leukocyte recruitment with large volume leukocytapheresis in healty volunteers. Ther Apher Dial 2006 10 : 396 403. (Pubitemid 44652199)
18. Ueki Y, Nakamura H, Kanamoto Y et al. Comparison of leukocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 2001 5 : 455 61.
19. Izumi Y, Tominaga M, Iwanaga N et al. Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis. Mod Rheumatol 2006 16 : 20 3.